CORTICE BIOSCIENCES, INC.

PrivateCIK: 2032216
Location

NEW YORK, NY

CORTICE BIOSCIENCES, INC. enters CNS PHARMACEUTICALS, INC. with 573.37K shares — 100% direct ownership

Full direct ownership at entry is the strongest form of insider alignment with shareholders.

Direct
InsiderCORTICE BIOSCIENCES, INC.CIK 2032216
IssuerCNS PHARMACEUTICALS, INC.CIK 1729427
10% Owner
Since Jul 2024
573.37K
Baseline shares
100% direct
573.37K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned573.37K
Total
573.37K direct573.37K
Derivative Holdings0
No derivative holdings reported
CORTICE BIOSCIENCES, INC. — Initial Ownership Disclosure (Form 3) Filed Aug 6, 2024 | Finecho